Thrombolysis of basilar artery occlusion--intra-arterial or intravenous: is there really no difference?
Schulte-Altedorneburg
Gernot
G
Reith
Wolfgang
W
Brückmann
Hartmut
H
Dichgans
Martin
M
Mayer
Thomas E
TE
D001488:Basilar Artery / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D002986:Clinical Trials as Topic / Q000592:standards / Q000706:statistics & numerical data; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007269:Injections, Intra-Arterial / Q000592:standards / Q000706:statistics & numerical data; D007275:Injections, Intravenous / Q000592:standards / Q000706:statistics & numerical data; D011183:Postoperative Complications / Q000517:prevention & control; D011300:Preoperative Care / Q000379:methods / Q000592:standards; D015912:Thrombolytic Therapy / Q000379:methods / Q000592:standards* / Q000706:statistics & numerical data; D016896:Treatment Outcome; D014715:Vertebrobasilar Insufficiency / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
D005343:Fibrinolytic Agents